Temasek’s Accuron MedTech leads $1.9m pre-series A in Singapore startup Advent Access

Photo: Pixabay

Temasek Holdings’ unit Accuron MedTech has led a S$2.6 million  ($1.9 million) pre-Series A round in Singapore-based startup Advent Access, which is developing a vascular access device for dialysis patients, according to an announcement.

Continue reading this story with a subscription to DealStreetAsia.

Subscribe

Contact us for corporate subscriptions at subs@dealstreetasia.com.